It’s only fair to share… glucagon EMA……Ogluo (glucagon), a hybrid medicine for the treatment of severe hypoglycaemia in diabetes mellitus. Hybrid applications rely in part on the results of pre-clinical tests and clinical trials of an already authorised reference product and in part on new data. On 10 December 2020, the Committee for Medicinal Products for Human Use (CHMP) adopted …